60750-37-0

Basic information

• Product Name: 1,2,3,4-Tetrahydro-6-methyl-2-oxo-4-phenyl-5-pyrimidinecarboxylic acid
• Synonyms: 1,2,3,4-Tetrahydro-6-methyl-2-oxo-4-phenyl-5-pyrimidinecarboxylic acid;6-Methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid
• CAS NO: 60750-37-0
• Molecular Formula: C₁₂H₁₂N₂O₃
• Molecular Weight: 232.24
• Mol File: 60750-37-0.mol
• Article Data: 14

Chemical Properties

• Melting Point: 210 °C(Solv: ethanol (64-17-5))
• Boiling Point: 405.9±45.0 °C(Predicted)
• Appearance: /
• Density: 1.285±0.06 g/cm3(Predicted)
• PKA: 6.73±0.40(Predicted)
• CAS DataBase Reference: 1,2,3,4-Tetrahydro-6-methyl-2-oxo-4-phenyl-5-pyrimidinecarboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,4-Tetrahydro-6-methyl-2-oxo-4-phenyl-5-pyrimidinecarboxylic acid(60750-37-0)
• EPA Substance Registry System: 1,2,3,4-Tetrahydro-6-methyl-2-oxo-4-phenyl-5-pyrimidinecarboxylic acid(60750-37-0)

Safety Data

• Hazardous Substances Data: 60750-37-0(Hazardous Substances Data)

Usage

General Description

1,2,3,4-Tetrahydro-6-methyl-2-oxo-4-phenyl-5-pyrimidinecarboxylic acid is a chemical compound with a complex molecular structure. It is a derivative of pyrimidinecarboxylic acid, containing a methyl group and a phenyl group. 1,2,3,4-Tetrahydro-6-methyl-2-oxo-4-phenyl-5-pyrimidinecarboxylic acid is likely to possess pharmaceutical properties due to its structural features, and it may have potential applications in medicinal chemistry. It is important to handle and use this compound with caution and ensure proper safety measures are in place, given its complex and potentially reactive nature.

Upstream product

• 674-82-8 4-methyleneoxetan-2-one 
• 100-52-7 benzaldehyde 
• 57-13-6 urea 
• 2440-60-0 2-methyl-isourea 
• 60750-23-4 benzyl 6-methyl-4-phenyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate 
• 100-51-6 benzyl alcohol 
• 541-50-4 2-acetoacetic acid 
• 188780-24-7 5-methoxycarbonyl-6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one 
• 123237-03-6 ethyl 6-methyl-4-phenyl-3,4-dihydropyrimidin-2(1H)-one-5-carboxylate 

Downstream Products

• 30570-16-2 6-methyl-4-phenyl-2-oxo-1,2,3,4-tetrahydropyrimidine 
• 1250832-25-7 C₁₁H₁₁BrN₂O 
• 1250832-26-8 C₁₁H₁₁IN₂O 
• 1442442-64-9 C₁₉H₁₈N₂O₄ 
• 1442442-75-2 C₂₀H₂₁N₃O₃ 
• 1314801-55-2 N-cyclohexyl-4-phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxamide 

Relevant articles and documents

One pot synthesis of micromolar BACE-1 inhibitors based on the Dihydropyrimidinone scaffold and their Thia and Imino analogues

A library of dihydropyrimidinones was synthesized via a “one-pot” three component Biginelli reaction using different aldehydes in combination with β-dicarbonyl compounds and urea. Selected 2-thiooxo and 2-imino analogs were also obtained with the Biginell

Design, Synthesis, and Anti-HIV-1 Evaluation of a Novel Series of 1,2,3,4-Tetrahydropyrimidine-5-Carboxylic Acid Derivatives

A series of tetrahydropyrimidine derivatives (2a – 2l) were designed, synthesized, and screened for anti-HIV-1 properties based on the structures of HIV-1 gp41 binding site inhibitors, NB-2 and NB-64. A computational study was performed to predict the pharmacodynamics, pharmacokinetics, and drug-likeness features of the studied molecules. Docking studies revealed that the carboxylic acid group in the molecules forms salt bridges with either Lys574 or Arg579. Physiochemical properties (e.g., molecular weight, number of hydrogen bond donors, number of hydrogen bond acceptors, and number of rotatable bonds) of the synthesized compounds confirmed and exhibited that these compounds were within the range set by Lipinski's rule of five. Compounds 2e and 2k with 4-chlorophenyl substituent and 4-methylphenyl group at C(4) position of the tetrahydropyrimidine ring was the most potent one among the tested compounds. This suggests that these compounds may serve as leads for development of novel small-molecule HIV-1 inhibitors.

Synthesis method of 3,4-dihydropyrimidin-2-ketone compounds catalyzed by ionic liquid at room temperature

The present invention discloses a synthesis method of 3,4-dihydropyrimidin-2-ketone compounds catalyzed by ionic liquid at room temperature. Key technology is as follows: nano-silicon-loaded bronsted acid functional group ionic liquid is used as a catalys